Applications of single-cell transcriptomics: updated insights in endometrial cancer
Clinical and Translational Oncology · 2025
DOI: 10.1007/s12094-025-04032-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2025. Verfasst von Shuyue Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Women's Hospital of Nanjing Medical University & Nanjing Women and Children's Healthcare Hospital, 123 Tianfeixiang, Nanjin…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Single-Cell Analysis, Tumor Microenvironment, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Nanjing Medical Science and Technique Development Foundation, Wu Jieping Medical Foundation, "333 Project" of Jiangsu Province.
Abstract (Originalsprache)
Endometrial cancer (EC) presents a major global health challenge due to its heterogeneity and complex pathophysiology. The tumor microenvironment (TME), comprising stromal cells, immune cells, endothelial cells, and non-cellular components, critically influences EC progression. Single-cell RNA sequencing (scRNA-seq) has revolutionized our understanding of EC by revealing TME cellular heterogeneity and interactions. This review synthesizes recent scRNA-seq applications in EC, focusing on two key areas: ① Mapping transcriptional heterogeneity across major cellular components (epithelial, stromal, endothelial, and immune cells); ② Elucidating the factors driving tumor evolution, immune evasion, and differential immunotherapy response. Collectively, these scRNA-seq-derived insights into the dynamic TME ecosystem provide the foundation for translating basic discoveries toward clinical applications. Such advances could thereby promote TME-based personalized therapies and more accurate prognostic predictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Women's Hospital of Nanjing Medical University & Nanjing Women and Children's Healthcare Hospital, 123 Tianfeixiang, Nanjing, 210004, China.
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, 210009, China.
- Department of Gynecology, Women's Hospital of Nanjing Medical University & Nanjing Women and Children's Healthcare Hospital, 123 Tianfeixiang, Nanjing, 210004, China. gongzhen@njmu.edu.cn.
- Center of Clinical Laboratory Science, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, 210009, China. slzhong@njmu.edu.cn.
Förderung
- Nanjing Medical Science and Technique Development Foundation
- Wu Jieping Medical Foundation
- "333 Project" of Jiangsu Province
- Key Medical Research Project of Jiangsu Provincial Health Commission
- Natural Science Foundation of Jiangsu Province
- “333 Project” of Jiangsu Province
Zitieren
APA
Xiao, S., Li, H., Liu, J., Xie, X., Xu, H., Gong, Z., & Zhong, S. (2025). Applications of single-cell transcriptomics: updated insights in endometrial cancer. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04032-7
Vancouver
Xiao S, Li H, Liu J, Xie X, Xu H, Gong Z, et al. Applications of single-cell transcriptomics: updated insights in endometrial cancer. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04032-7
BibTeX
@article{Xiao2025,
author = {Xiao, Shuyue and Li, Huixin and Liu, Jianyao and Xie, Xinyi and Xu, Hanzi and Gong, Zhen and Zhong, Shanliang},
title = {Applications of single-cell transcriptomics: updated insights in endometrial cancer},
journal = {Clinical and Translational Oncology},
year = {2025},
doi = {10.1007/s12094-025-04032-7}
}
EUVIMED